Home › Funds › Atom Investors LP › ABT
Atom Investors LP position in ABT
ABBOTT LABORATORIES · Health Care
Atom Investors LP reported holding 50,174 shares of ABT (ABBOTT LABORATORIES) in its Q2 2026 13F filing — a position valued at US$4.6M, representing 0.41% of its reported portfolio and ranking #32 among its reported holdings. Atom Investors LP has disclosed ABT holdings in 10 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Atom Investors LP's ABT position evolved
Atom Investors LP first disclosed a stake in ABT in Q3 2023 at 26,409 shares (US$2.6M). The position peaked in Q2 2024 at 102,089 shares, worth US$10.6M. Across 10 filings, Atom Investors LP increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 50,174 shares valued at US$4.6M — an increase of 29,265 shares quarter over quarter.. Notable position changes include a 65% increase in Q4 2023 (shares rose 4% over the following quarter), a 59% trim in Q1 2025 (shares rose 3% over the following quarter), a 140% increase in Q2 2026 (shares rose 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 26.41K | $2.56M | New |
| Q4 2023 | 43.48K | $4.79M | Add |
| Q1 2024 | 68.32K | $7.76M | Add |
| Q2 2024 | 102.09K | $10.61M | Add |
| Q3 2024 | 43.56K | $4.97M | Reduce |
| Q4 2024 | 36.22K | $4.10M | Reduce |
| Q1 2025 | 14.71K | $1.95M | Reduce |
| Q3 2025 | 2.10K | $280.60K | New |
| Q1 2026 | 20.91K | $2.15M | New |
| Q2 2026 | 50.17K | $4.55M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABT and 13F data
ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABT
- Vanguard Group 175.56M sh · $22.00B · Q4 2025
- Charles Schwab Investment Management 59.67M sh · $5.41B · Q2 2026
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC 59.67M sh · $5.41B · Q2 2026
- Sixth Street Partners Management Company, L.P. 59.67M sh · $5.41B · Q2 2026
- Capital Research Global Investors 36.91M sh · $3.35B · Q2 2026
- Capital Research Global Investors 36.91M sh · $3.35B · Q2 2026
- Capital International Investors 34.65M sh · $3.15B · Q2 2026
- Deutsche Bank AG 16.71M sh · $1.52B · Q2 2026
More on Atom Investors LP
FAQ
How long has Atom Investors LP held ABT?
Atom Investors LP has disclosed ABT holdings in 10 of the last 12 reported quarters, going back to Q3 2023.
What is Atom Investors LP's current position in ABT?
As of Q2 2026, Atom Investors LP holds 50.17K shares of ABT (ABBOTT LABORATORIES), valued at $4.55M, representing 0.41% of its reported portfolio and ranking #32.
Has Atom Investors LP been buying or selling ABT?
In the latest 13F filing (Q2 2026), Atom Investors LP increased its position in ABT. The position peaked in Q2 2024 at 102.09K shares.
Which other funds hold ABT?
Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.